Study title: Report/protocol/study N°: Clinical trial of Orofar Investigator: A. Monteverde Report date: 18 Sep 1986 Design: open, non comparative Objective: Evaluation of efficacy and safety of Orofar gelsolets Population: subjects with acute pharyngitis or tonsillitis Evaluations: body temperature, pharyngeal pain, swallowing difficulties, dysphonia, inflammation, side effects Total: 20 Age (mean, range): 13-82 years
| Type of medicine: Medicines containing chemical active substances | |||||
| Therapeutic area: Skin and Connective Tissue Diseases [C17] | |||||
| Brands: Please see report, Please see report, Please see report, Please see report, Please see report, Please see report | |||||
| MAH holders: Please see report, Please see report | |||||
| Assessment: | |||||
| Active substance: BENZOYL PEROXIDE | |||||
| ATC code: | |||||
| Document link: | |||||
| Document date: | |||||
| Study number: CR.U9401 - 00-4956 | |||||
| EudraCT number: | |||||
| Scope of study: Clinical | |||||
| Population of study subjects: | Preterm newborn Infants | Newborn infants (1 to 27 days) | Infants and toddlers (28 days to 24 months) | Children (2 to 11 years) | Adolescents (12 to 18 years) |
| - | - | - | - | - | |